B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies.
Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
K
K
Bojarczuk
Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
M
M
Siernicka
Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
M
M
Dwojak
Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
M
M
Bobrowicz
Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
B
B
Pyrzynska
Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
P
P
Gaj
Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
M
M
Karp
Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
K
K
Giannopoulos
International Centre for Genetic Engineering and Biotechnology, Molecular Hematology Group, Campus A. Buzzati-Traverso, Rome, Italy.
D G
DG
Efremov
IBiSA Cancer Immunomonitoring Platform, Institut Paoli Calmettes, UM 105, Aix-Marseille Université, Marseille, France.
C
C
Fauriat
1] Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland [2] Department 3, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
J
J
Golab
Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
M
M
Winiarska
D000911:Antibodies, Monoclonal / Q000276:immunology*; D018951:Antigens, CD20 / Q000276:immunology*; D006801:Humans; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011947:Receptors, Antigen, B-Cell / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D011947:Receptors, Antigen, B-Cell